Cisiv Ltd’s Post

Global Heart Hub, in partnership with The Health Policy Partnership, developed a global roadmap to support #patient organisations and other advocates, including healthcare professionals and researchers, in driving shared decision-making best practices for people with #heartvalvedisease in their countries. This roadmap, "Paving the way: a roadmap to the successful implementation of shared decision-making in heart valve disease", will help improve patient access to #shareddecisionmaking by addressing the perceived barriers. The roadmap highlights the need for a gold standard for shared decision-making in #HVD as there is currently no standardised model available at the national or international level. Learn more - https://lnkd.in/d9iSYrrw #HeartSDM

Unlock insights into rare diseases through patient registries! Lifebit's latest blog reveals how these registries are transforming research with four key benefits. From overcoming data limitations to fostering collaboration, patient registries are changing how we understand and treat rare conditions. Join the discussion now: https://bit.ly/42MP2Ts #RareDisease #PatientRegistries #HealthTech #Lifebit

Even as a healthy individual, participating in clinical trials is invaluable. Your involvement contributes to medical breakthroughs, helping researchers understand disease prevention, treatment, and overall health. By joining trials, you play a crucial role in advancing science and improving healthcare for everyone. Be a part of the journey towards a healthier future. 🔬 #ClinicalTrials #ClinicalResearch #Health #Medicine #MedicalAdvancements #HealthResearch #HealthyVolunteers #Doctor

Boosting participation in clinical trials, especially among diverse and eligible patients, is vital. Firma understands that study duration, visit frequency, disease state, or distance to the study site should never be barriers. That's why we specialize in tailoring comprehensive protocol-specific #MobileNursing solutions. Choose Firma for a game-changing approach to ensure everyone has the opportunity to take part in your research. #EveryTrialEveryPatient ➡️ https://bit.ly/3FDChQs

𝐖𝐡𝐚𝐭 𝐈𝐬 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞? 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬, 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 Personalized healthcare, also known as precision medicine or personalized medicine, is a method of medical care in which the unique characteristics of each patient, including their genetic makeup, medical history, and lifestyle, are taken into account when making decisions regarding disease prevention, diagnosis, and treatment. Read Complete Article: https://lnkd.in/deq58Bt4 #Readmagazine #Artificialintelligence #healthcare #personalizedmedicine #PreventiveMedicine #DataNoise #DataManagement #PatientEngagement

Do nonspecific symptoms have you questioning a diagnosis? Visit HighlightHLH.com, our new website for healthcare professionals to learn when hemophagocytic lymphohistiocytosis (HLH) might be the answer. HighlightHLH.com explores the diagnosis and management of HLH and provides important considerations for testing. Learn more: https://bit.ly/3Uk9GYO

HCNSW would like to take a moment to thank and celebrate those who participate in clinical trials! It is such an important role, and helps all of us receive quality, effective, and safe healthcare🌻 "Clinical trials provide the evidence for what works for whom, when, and the safety of those interventions... helping to improve understanding of disease, diagnosis, treatment, cure and prevention of health conditions." Thank you also to researchers, organisations, health professionals, and all who make clinical trials possible! Find out more here, including a free webinar! ➡️https://buff.ly/4blU2Cf #ICTD24 #ClinicalTrialsDay #ClinicalTrial #Research

A key factor in the diagnosis of Alzheimer’s disease (AD) in its earliest stages: the involvement of primary care physicians (PCPs). In this clip, Arif Dalvi, MD, MBA, highlights why PCPs are on the frontlines of AD detection. Watch the full video: https://ow.ly/y0gv50Smvw1 Additionally, this presentation is intended for U.S. based health care professional audiences only. #AlzheimersAndBrainAwarenessMonth #AlzheimersDisease #EndAlz

Some hospitals may start using new techniques for disease diagnosis or treatment before fully understanding if the benefits outweigh the cost. New data analysis is aiming to gather more real-world data around the effectiveness of these new tools before they dig deeply into hospital pockets. Read the J&J Innovative Medicine Belgium article here: https://lnkd.in/em7j-8uy #datascience #healthcare

Boosting participation in clinical trials, especially among diverse and eligible patients, is vital. Firma understands that #StudyDuration, visit frequency, disease state, or distance to the study site should never be barriers. That's why we specialize in tailoring comprehensive protocol-specific solutions. Choose Firma for a game-changing approach to ensure everyone has the opportunity to take part in your research. #EveryTrialEveryPatient ➡️ https://bit.ly/3FDChQs